Toll like receptors agonists-based nanomedicines as veterinary immunotherapies
Many infections affecting animals enter across mucosa, needing of secretory immunity to re-ject the disease; protection against some pathogens must be early, fast, and specifically elicited, while from others must be wide enough to fight against variable serotypes. Today, however, most veterinary va...
Main Authors: | Eder L Romero, Federico L Parra, María J Morilla |
---|---|
Format: | Article |
Language: | English |
Published: |
Andover House Inc.
|
Series: | Precision Nanomedicine |
Online Access: | http://prnano.scholasticahq.com/article/13493-toll-like-receptors-agonists-based-nanomedicines-as-veterinary-immunotherapies.pdf |
Similar Items
-
Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy
by: Max E. Kirtland, et al.
Published: (2020-11-01) -
Trial Watch: Toll-like receptor agonists in cancer immunotherapy
by: Melody Smith, et al.
Published: (2018-12-01) -
Toll-Like Receptor 9 Agonists in Cancer
by: Karapetyan L, et al.
Published: (2020-10-01) -
Engineering Therapeutic Strategies in Cancer Immunotherapy via Exogenous Delivery of Toll-like Receptor Agonists
by: Sehwan Jeong, et al.
Published: (2021-08-01) -
Toll-Like Receptor-Based Strategies for Cancer Immunotherapy
by: Saghar Pahlavanneshan, et al.
Published: (2021-01-01)